LAUREN ROGERS: Open Payments
NPI 1629709621 · LAPEER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 92 payments from 20 companies in 2025. Trend: 2023 $1,375 · 2024 $1,084 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $286 |
| ABBVIE INC. | 25 | $258 |
| AstraZeneca Pharmaceuticals LP | 8 | $186 |
| HARMONY BIOSCIENCES LLC | 9 | $159 |
| Novo Nordisk Inc | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| PFIZER INC. | 3 | $49 |
| Astellas Pharma US Inc | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $39 |
Products named: VRAYLAR, WAKIX, KRYSTEXXA, OTEZLA, FARXIGA, REXULTI, Kerendia, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
